Schedule 13G ownership disclosure
ACRIVON THERAPEUTICS INC
Security class unavailable · CUSIP: 004890109
Event date: 2024-04-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-095564
- Form type
- SC 13G
- Filer
- Acrivon Therapeutics, Inc.
- CIK
- CIK 1781174
- Filed
- Apr 15, 2024
- Reporting period
- Apr 11, 2024
- Description
- Schedule 13G beneficial ownership